About Us
Connecting to Asian Air Sensors...
Research Watch
How Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child AbuseNew Study Highlights Metabolism Risks in Combination Antidepressant Therapy in NepalNew Study Reveals Hidden Environmental Drivers Behind Nepal’s Ongoing Cholera BattleThe Silent Pandemic: Kathmandu’s Poultry Industry Is Breeding Untreatable SuperbugsThe Silent Emergency: Domestic Violence and the Mental Health Crisis Among Nepalese WomenNepal’s Drug-Resistant TB Rates Hold Steady, but New Antibiotic Resistance Sparks ConcernHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child AbuseNew Study Highlights Metabolism Risks in Combination Antidepressant Therapy in NepalNew Study Reveals Hidden Environmental Drivers Behind Nepal’s Ongoing Cholera BattleThe Silent Pandemic: Kathmandu’s Poultry Industry Is Breeding Untreatable SuperbugsThe Silent Emergency: Domestic Violence and the Mental Health Crisis Among Nepalese WomenNepal’s Drug-Resistant TB Rates Hold Steady, but New Antibiotic Resistance Sparks Concern

Tools to help patients and other stakeholders' input into choice of intercurrent event strategy for estimands in randomised trials.

Researchers

Joanna Hindley, Charlotte Hartley, Jennifer Hellier, Kate Sturgeon, Sophie Greenwood, Ian Newsome, Katherine Barrett, Debs Smith, Tra My Pham, Dongquan Bi, Beatriz Goulao, Suzie Cro, Brennan C Kahan

Abstract

Estimands can help to clarify the research questions being addressed in randomised trials. Because the choice of estimand can affect how relevant trial results are to patients and other stakeholders, such as clinicians or policymakers, it is important for them to be involved in these decisions. However, there are barriers to having these conversations. For instance, discussions around how intercurrent events (post-randomisation events which affect the interpretation or existence of the outcome) should be addressed in the estimand definition typically involve complex concepts as well as technical language. We aimed to provide tools that could facilitate conversations between researchers and patients and other stakeholders about the choice of intercurrent event strategy for estimands. We developed three tools: (i) a video explaining the concept of an estimand and the five different ways that intercurrent events can be incorporated into the estimand definition; (ii) an infographic outlining these five strategies; and (iii) an editable PowerPoint slide which can be completed with trial-specific details to facilitate conversations around choice of estimand for a particular trial. Each tool was produced through collaboration between researchers and public partners. This involved (i) an initial meeting between researchers and public partners to discuss the aims of the tool; (ii) a draft of the tool being prepared by the research team; (iii) public partners providing feedback; and (iv) the research team updating and finalising the tool. These resources can help to start conversations between the trial team and patients and other stakeholders about the best choice of estimand and intercurrent event strategies for a randomised trial. The video and infographic-which explain estimands and intercurrent events with reference to imagined examples-can be sent to stakeholders in advance of a consultation, or presented in the meeting itself. It is important that a member of the trial team is available to answer questions or clarify concepts following this. The editable slide can be completed by the trial team with the specific details of their trial, and then shown to patients or other stakeholders during the meeting to facilitate discussion around which intercurrent event strategy is most relevant for the trial. An example of a completed editable slide is also provided for an example weight loss trial. We developed three tools to help researchers to have conversations with patients and other stakeholders about estimands, and how intercurrent events should be incorporated into the target estimand for a randomised trial. Further work to evaluate the tools in real-world settings across different stakeholder groups could help to validate the tools and reveal any further refinements necessary to improve their utility.
Source: PubMed (PMID: 42104488)View Original on PubMed
🌿

Blyss

Your Health Guide · The Health Thread

🌿
Hi, I'm Blyss 🌿 Your personal health guide on The Health Thread. I can help you find articles, tools, and health resources. How can I help you today?

⚕️ Not medical advice. Always consult a qualified doctor.